| United States Patent Application |
20020183284
|
| Kind Code
|
A1
|
|
Yarbrough, William M.
|
December 5, 2002
|
Urushiol induced contact dermatitis solution
Abstract
A solution for urushiol induced contact dermatitis is provided for in a
topical solution. According to the invention, a method is provided for
applying a composition of substances to the affected area, working the
composition into the affected area, and removing the composition from the
affected area. The composition comprises at least one ethoxylate in
combination with a supporting agent. It is believed that this combination
binds to the available urushiol receptors rendering it inactive. The
affinity of the receptors for the ethoxylates also appears to cause a
release of the urushiol from its epidermal bonds for bonding to the
composition. An inert scrubbing agent, such as polyethylene beads, can
also be included to assist in the release of the urushiol. Acetylated
lanolin alcohol, EDTA, a foam stabilizer, and water can also be added to
the composition without effecting performance.
| Inventors: |
Yarbrough, William M.; (Peoria, IL)
|
| Correspondence Address:
|
Robert L. Knechtel
1105 Moraine Drive
Woodstock
IL
60098
US
|
| Serial No.:
|
200691 |
| Series Code:
|
10
|
| Filed:
|
July 22, 2002 |
| Current U.S. Class: |
514/129; 424/401; 424/639; 424/94.4 |
| Class at Publication: |
514/129; 424/401; 424/639; 424/94.4 |
| International Class: |
A61K 038/44; A01N 057/00; A61K 007/00; A01N 059/16; A61K 033/32 |
Claims
I claim:
1. A solution for urushiol induced contact dermatitis comprising a
supporting agent and at least one ethoxylate in combination.
2. The solution for urushiol induced contact dermatitis of claim 1 wherein
one of the at least one ethoxylate is a nonyl phenyl ethoxylate.
3. The solution for urushiol induced contact dermatitis of claim 1 further
wherein the supporting agent is sodium lauroyl sarcosinate.
4. The solution for urushiol induced contact dermatitis of claim 1 further
wherein the supporting agent is d-limonene.
5. The solution for urushiol induced contact dermatitis of claim 1 further
including Acetylated lanolin alcohol.
6. The solution for urushiol induced contact dermatitis of claim 1 further
including a scrubbing agent.
7. The solution for urushiol induced contact dermatitis of claim 6 wherein
the scrubbing agent is polyethylene granules.
8. The solution for urushiol induced contact dermatitis of claim 6 wherein
the scrubbing agent is pumice.
9. The solution for urushiol induced contact dermatitis of claim 1 further
including water.
10. The solution for urushiol induced contact dermatitis of claim 1
further including ethylenediaminetetraacetic acid.
11. The solution for urushiol induced contact dermatitis of claim 1
further including a foam-stabilizing agent.
12. The solution for urushiol induced contact dermatitis of claim 1
further including a cutting agent.
13. The cutting agent of claim 12 being selected from the group of aqueous
based solutions and oil based solutions.
14. A solution for urushiol induced contact dermatitis comprising at least
one ethoxylate, a supporting agent, and scrubbing means.
15. The solution for urushiol induced contact dermatitis of claim 14
wherein one of the at least one ethoxylate is a nonyl phenyl ethoxylate.
16. The solution for urushiol induced contact dermatitis of claim 14
further wherein the supporting agent is sodium lauroyl sarcosinate.
17. The solution for urushiol induced contact dermatitis of claim 14
further wherein the supporting agent is d-limonene.
18. The solution for urushiol induced contact dermatitis of claim 18
wherein the scrubbing agent is polyethylene granules.
19. The solution for urushiol induced contact dermatitis of claim 18
wherein the scrubbing agent is pumice.
20. The solution for urushiol induced contact dermatitis of claim 14
further including water.
21. The solution for urushiol induced contact dermatitis of claim 14
further including Acetylated lanolin alcohol.
22. The solution for urushiol induced contact dermatitis of claim 14
further including ethylenediaminetetraacetic acid.
23. The solution for urushiol induced contact dermatitis of claim 14
further including a foam-stabilizing agent.
24. The solution for urushiol induced contact dermatitis of claim 14
further including a cutting agent.
25. The cutting agent of claim 14 being selected from the group of aqueous
based solutions and oil based solutions.
26. A method for treating contact dermatitis comprising the steps of:
preparing a composition comprising at least one ethoxylate and a
supporting agent; applying the composition to an affected area; scrubbing
the composition on the affected area; permitting the composition to
remain on the affected area a sufficient amount of time to enable the
composition of matter to cause an effect; and, removing the composition
from the affected area.
27. The method of claim 26 including the further step of adding a
scrubbing agent to the composition
28. The method of claim 26 wherein the scrubbing agent is polyethylene
granules.
29. The method of claim 26 wherein the scrubbing agent is pumice.
30. The method of claim 26 wherein preparing the composition further
includes adding Acetylated lanolin alcohol.
31. The method of claim 26 wherein preparing the composition further
includes adding water.
32. The method of claim 26 wherein preparing the composition further
includes EDTA.
33. The method of claim 26 wherein preparing the composition further
includes a foam stabilizer.
34. The method of claim 26 further including the step of adding a thinning
agent to the composition.
Description
I. RELATED APPLICATION
[0001] This application is a Continuing Prosecution Application (CIP type)
of parent application Ser. No. 09/347,714.
II. FIELD OF THE INVENTION
[0002] The present invention relates to solutions for allergic dermatitis
and more particularly to a solution for Toxicodendron dermatitis, which
results from contact with the Rhus oleoresin, urushiol.
II. BACKGROUND OF THE INVENTION AND PRIOR ART
[0003] Urushiol is the toxin responsible for the dermatitis caused by
contact with the sap of commonly encountered noxious plants such as
poison ivy (T. rydbergii (Northern and Western poison ivy) and T.
radicans ssp. radicans (Eastern poison ivy)), poison oak (T. toxicarium
(Eastern poison oak) and T. diversilobum (Western poison oak)), poison
sumac (T. vernix), and related plants found throughout the world. These
plants are in the Anacardiaceae group, which also includes, among others,
the lacquer tree of Asia, the mango tree, cashew shell oil, and certain
nutshells, such as the walnut. (Throughout this document, reference to
poison ivy is meant to also include other urushiol containing plants.)
[0004] When located inside an unruptured plant, urushiol is a light,
colorless oil. When exposed to oxygen, urushiol easily oxidizes and,
after polymerizing, turns a blackish color. The slightest contact or even
breeze easily damages the leaves. Therefore, it is rare to find a plant
that does not have at least some ruptured leaves. Most people believe
that poison ivy infection can only result from contact with the leaves of
the plant. This is not true. Urushiol is found not only in the leaves but
also vines and stem and root systems. The urushiol in the root system and
vines is pure and is ten to 100 times more potent than that found in
leaves. Accordingly, contact with cut or broken vines, or root systems
will almost always result in a reaction.
[0005] Experts estimate there are up to 55 million cases of
urushiol-induced contact dermatitis annually in the United States.
Roughly 85 percent of all people will develop an allergic reaction when
adequately exposed to poison ivy. People who reach adulthood without
becoming sensitive have only a 50 percent chance of developing an allergy
to poison ivy. Sensitivity to poison ivy tends to decline after 72 years
of age as the immune system is less reactive. Children under the age of 1
year do not typically react to urushiol as their immune systems are not
yet fully developed.
[0006] The American Academy of Dermatology estimates that there are up to
50 million cases of urushiol induced contact dermatitis annually in the
United States alone. No one is sure of the number of world wide annual
exposures but some experts estimate that the number could be double that
of the United States. Accordingly, urushiol induced contact dermatitis is
a world wide problem.
[0007] Chemically, urushiols are mixtures of catechols with long,
hydrophobic, carbon (alkyl) side chains at the three position of the
catechol ring. For example, poison ivy contains predominantly
3-n-pentadececylcatechols (C-15) and poison oak contains predominantly
3-n-heptaecylcatechols (C-17).
[0008] Current theory suggests that the reaction to urushiol is a delayed
cell-mediated immune response in which, upon first exposure, urushiol
penetrates the stratified squamous epithelial cells and binds to the
Langerhan cells, which, in turn, sensitize effector T-cells in the lymph
system. Subsequent exposures to urushiol result in the release of
cytokines and reaction by macrophages and cytotoxic T-Cells. The result
of lytic enzyme and perforin release is destruction of the membrane-bound
urushiol and surrounding skin cells, which presents as the commonly seen
clinical picture.
[0009] Once urushiol touches the skin, it begins to penetrate in minutes.
It is completely bound to the skin after eight hours (two to six hours
according to some experts). The rash generally develops within two days.
Redness and swelling occur, often followed by blisters and severe
itching. In a few days, the blisters may become crusted and begin to
scale. The rash generally peaks after five days, and starts to decline
after about a week or 10 days. The rash takes two or more weeks to heal.
In a severe case or in a systemic reaction, individuals will many times
present with black spots in areas of heavy urushiol concentration. The
black spots are polymerized urushiol in a pure form and need to be
removed immediately. This "Black Spot" test (attributed to Guin) is good
indicator of a severe reaction, localized or systemic, or is often seen
in cases of poison oak (typically a more tenacious reaction than poison
ivy).
[0010] The rash can affect almost any part of the body, especially where
the skin is thin, such as on the face. A rash develops rarely on the
soles of feet and palms of hands, where the skin is thicker. The rash
does not spread, although it may seem to do so when it breaks out in new
areas. This may happen because urushiol absorbs more slowly into skin
that is thicker, such as on forearms, legs and the body's trunk. Urushiol
can be transferred by fingernails or animal fur and can remain on
clothing, shoes, and tools for up to five years in moist climates and
nine years in dry climates. Scratching the rash does not spread the
urushiol to other parts of the body, but it can prolong the discomfort
and cause a secondary infection.
[0011] Solution has historically consisted of attempting to remove the oil
as quickly after exposure as possible: applying rubbing alcohol, washing
affected areas with water, and showering with soap and water. In many
instances, however, people either fail to fully remove the toxin before
it has bound to the skin or don't realize they have been exposed until
after the rash appears.
[0012] Over-the-counter solutions are legion; a partial list of the most
popular includes hydrocortisone creams and ointments, diphenhydramine
gels, calamine lotion, and the proprietary product, Ivy Dry.RTM.*.
Hydrocortisone, diphenhydramine, and calamine lotion are palliatives and
offer only temporary relief from the itching associated with
Toxicodendron contact dermatitis. They do nothing to remove urushiol from
the skin. Likewise, Ivy Dry.RTM. provides essentially a cooling effect
that is only temporary. It may, if used before the urushiol binds to the
skin, remove some of the urushiol.
[0013] Attempts have been made to find both prophylactic solutions as well
as post-exposure solutions. To date, no vaccine has been developed and
the prior art solutions are not without shortcomings. One solution
example is seen in U.S. Pat. No. 5,686,074 to Stewart which teaches and
claims a solution for poison ivy which includes a composition including
linseed oil, an astringent, a starch, an essential oil and a citrus oil.
One shortcoming of this patent is that linseed oil can cause irritation
itself. A second shortcoming of this patent is that it requires that the
composition be applied to the affected areas up to twice a day until the
rash is gone. The composition provides what appears to be only very
temporary palliative relief of poison ivy symptoms and does not appear to
alter the course of the malady.
[0014] Other proposed solutions are seen in U.S. Pat. Nos. 5,620,527,
5,011,689 4,499,086, 4,259,318, 4,002,737, 3,862,331, 3,875,301, and
3,922,342.
[0015] Yet other prior art attempts have focused on prophylactics for
preventing the dermatitis. One example is seen is U.S. Pat. No. 4,663,151
to Waali that discloses and claims a prophylactic solution based upon
Aluminum Chlorhydrate.
[0016] Of course, the most significant shortcoming associated with
prophylactic solutions is that they are only effective if applied before
exposure to the urushiol; an occurrence that rarely takes place.
[0017] Tec Laboratories, Inc. of Albany, Oreg. markets an unpatented
product sold under the mark Tech-Nu. This product also is not without
shortcomings. This product was originally developed as a solution for
radiation exposure. It was discovered, however, that the product also
provided some relief for poison ivy exposure. The main active ingredient
in the Tech-Nu.RTM. product is Octylphenoxy-polyethoxyethanol. The four
octyl groups of this chemical are too large too surround the non polar
moieties in the urushiol. Therefore, it only partially matches the
polarity of urushiol. Thus, the action of this product renders the
urushiol only partially inactive. Since the urushiol remains partially
active and continues to cause irritation, only temporary relief is
provided and multiple applications are necessary. Also, the chemical
makeup of the product requires that it be applied no later than eight
hours after exposure to urushiol.
[0018] There is need, therefore, for a safe, effective solution for
dermatitis caused by exposure to the toxin urushiol. The solution should
provide complete relief from the signs and symptoms associated with the
dermatitis in limited solutions and be effective at any point during the
dermatitis cycle.
II. OBJECTS OF THE INVENTION
[0019] It is an object of the present invention to provide a solution for
urushiol induced allergic dermatitis (Toxicodendron dermatitis), the
solution providing almost immediate and permanent relief in usually one
solution.
[0020] It is a further object of the present invention to provide such a
solution that utilizes a composition that chemically attaches to
available urushiol receptors to block its allergic reaction properties
and to release the urushiol so that it can be removed from the skin.
[0021] It is a yet further object of the present invention to provide a
solution that is safe to use.
[0022] It is yet another object of the present invention to provide a
solution for urushiol induced allergic dermatitis that is topical, can be
purchased over the counter and is economical.
IV. SUMMARY OF THE INVENTION
[0023] The above objects of the invention are provided for in a topical
solution for use in urushiol induced contact dermatitis. According to the
invention, a composition of substances is applied to and worked into the
affected area. The solution is permitted to stay on the affected area a
sufficient amount of time such that the solution has bonded with the
urushiol, and the solution-urushiol complex is removed from the affected
area. A secondary effect of the solution is that it interacts with the C
fibers of the nervous system to provide itch relief.
[0024] The composition comprises at least one ethoxylate in combination
with a compatible wetting agent, for non-limiting example, Sodium Lauroyl
Sarcosinate (or SLS). It is believed that this combination creates an
urushiol-complimentary polar substance that binds with available urushiol
receptors rendering it inactive. The affinity of the receptors for the
ethoxylates also appears to cause a release of the urushiol from its
epidermal bonds creating a micelle with the inventive solution. An inert
scrubbing agent, such as polyethylene beads or pumice, can also be
included to assist in the release of the urushiol. Acetylated lanolin
alcohol, EDTA, a foam stabilizer, water and other various agents can also
be added to the composition without effecting performance.
V. DETAILED DESCRIPTION OF THE INVENTION
[0025] As noted above, urushiol is the toxin responsible for the contact
dermatitis caused by poison ivy, poison oak, and other urushiol
containing plants. When housed inside an unruptured plant leaf, urushiol
is a light, colorless oil. The slightest contact or even breeze easily
damages the leaves. Therefore, it is rare to find a plant that does not
have at least some ruptured leaves. When exposed to oxygen, urushiol
easily oxidizes and, after polymerizing, turns a blackish color.
[0026] The reaction experienced by most people is the result of exposure
to the oleoresin containing the urushiol. The reaction is an allergic
eczematous contact dermatitis characterized by redness, swelling,
papules, vesicles, bullae, and streaking. Urushiol is the name given to a
family catechols having long, hydrophobic, carbon (alkyl) side chains at
the three position of the catechol ring. The urushiol of the poison ivy
plant contains predominantly 3-n-pentadececylcatechols (C-15). Poison oak
is known to contain predominantly 3-n-heptaecylcatechols (C-17). Other
urushiol containing plants contain catechols that have side chains of
varying lengths.
[0027] The inventor discovered that a hand scrub product manufactured and
sold by the Redman Scientific, Company of Dallas, Tex. can alleviate the
signs and symptoms of urushiol induced contact dermatitis. The product
has been sold for approximately twenty years, and is known to be a safe,
gentle hypoallergenic product. The product has been sold as an industrial
hand cleaner and has never heretofore been known to be effective against
urushiol toxicity. It has only been promoted as a hand cleaner.
[0028] Chemical analysis and research has revealed that two of the
component parts of the Redman product are central to its effectiveness as
a solution for urushiol induced contact dermatitis: an ethoxylate and
Sodium Lauroyl Sarcosinate. The ethoxylate is a nonylphenol ethoxylate.
The present invention's ethoxylate has the large octyl groups removed. In
this way, the ethoxylate can "wrap" around the non-polar molecules of the
urushiol. Further, the long chain moiety of the present invention's
ethoxylate is only four carbons long, as opposed to, for example, that
seen in Tec-Nu.RTM.. This feature also assists the ethoxylate in bonding
to the urushiol more effectively. (It is important to note that more than
one surfactant can be used at a time. Accordingly, the ethoxylate may be
used alone or in conjunction with other surfactants to create the
appropriate environment.)
[0029] However, the ethoxylate itself is not capable of forming a complete
micelle with the urushiol. It was discovered that the addition of Sodium
Lauroyl Sarcosinate completes a micelle and the urushiol can be cleansed
away from the skin. SLS also has a long carbon chain that can surround
the non-polar portions of the urushiol. In addition, SLS contains a
highly polar end that aids in surrounding the polar ends of urushiol and
also in the invention's reactivity with water.
[0030] Thus, the combination of the ethoxylate and SLS create a large
molecule that contains flexible non-polar groups and soluble polar
groups. This permits the inventive composition to quickly and effectively
surround the urushiol and then be rinsed away with water, a highly polar
substance.
[0031] Further research by the Inventor has revealed that other substances
("hereinafter termed "supporting agents") also are effective in
combination with ethoxylates to bind and neutralize urushiol. For
example, d-limonene can be used in combination with an ethoxylate to
create an effective urushiol binding or neutralizing agent. The chemical
result of the ethoxylate/d-limonene combination has an affinity to
urushiol that is close but not the same as SLS; thus, d-limonene can be a
suitable, but somewhat less effective, substitute for SLS. Further,
d-limonene is known to be a mild skin irritant and may cause undue
irritation of already disrupted skin.
[0032] Other substances that form with the ethoxylate to form a molecule
that can create a micelle with the urushiol can also work as supporting
agents.
[0033] Inert scrubbing agents improve the action of the inventive
composition. The scrubbing agent assists by causing the urushiol to
detach from the skin and place it in position for bonding with the active
chemical components of the inventive composition. Any inert agent will
suffice but the inventor believes that polyethylene beads work best.
Another suitable inert agent includes pumice. The scrubbing agent should
be large enough to be effective but not so large as to cause abrasions.
Scrubbing agents should be in the range of 5 to 50 microns with an
average size being approximately 25 microns or 50 mesh. While scrubbing
agents are desirable, they are not critical to the invention use.
[0034] To make the inventive composition, an exact ratio of ethoxylate and
supporting agent is not critical. The only requirement is that the
ethoxylate completely reacts with the supporting agent, creating a
polymer. This will vary with the ethoxylate and supporting agent used,
but, in the case of SLS, a ratio of ethoxylate-to-SLS of 1.5:2 is
preferred. The amount by weight of scrubbing agent can vary according to
the grittiness desired. In the case of SLS and polyethylene beads, a
formula of ethoxylate:SLS:polyethylene of 40:20:40 is preferred but that
formulas of other concentrations are useful. Thus, for production
purposes, formulas having a supporting agent ranging from 10 to 20% by
weight, ethoxylate ranging from 20 to 40% by weight, and scrubbing agent
from 20 to 50% by weight are reasonable. But again, the formula is not
restricted to these ranges, which ranges are presented for example
purposes only.
[0035] Also, a cutting agent that does not chemically react with the
composition may be added but is not required. The cutting agent makes the
overall composition flow more easily, thereby enabling more packaging
options such as tubes. The cutting agent can be either an aqueous based
solution or an oil based solution. The cutting agent must be added only
in sufficient amount that it promotes flow but does not effect the action
of the composition.
[0036] Thus, a representative composition for the inventive solution might
be polyethylene granules, sodium lauroyl sarcosinate, nonoxynol-9, C12-15
pareth-9, disodium EDTA, quaternium-15, carbomer 2%, triethanolamine, and
water.
[0037] In use, the composition is applied to an affected area and worked
over the area by a scrubbing motion. After sufficient time has elapsed to
ensure that the affected area has been adequately exposed to the
composition, typically thirty seconds to three minutes depending on the
agents used, severity of the reaction, and the sensitivity of the
individual, the composition and bound urushiol are washed away. To have
the greatest effect, the composition can be left on the affected area,
after the initial scrubbing, for a short time, thirty to sixty seconds, a
second rubbing can be accomplished. The second rubbing period can be
shorter than the initial period and than washed away. Experiments have
demonstrated that a majority of people needs only one solution to be
relieved of itching; however, severe or systemic cases may require two or
more application approximately eight hours apart for two days to be fully
effective. The inventive composition works at varying rates of
effectiveness at any time during the rash cycle.
* * * * *